LuminOre CopperTouch(TM) Formed to Respond to Ongoing Healthcare Crisis Through Education About the Antimicrobial Properties of Copper
New company, LuminOre CopperTouch, will address growing problem of infections in medical facilities.
Carlsbad, CA, November 23, 2011 --(PR.com)-- Thomas Valente, President and CEO, has announced the formation of LuminOre CopperTouch, a new company from the inventor of LuminOre Composite Metals (TM). The new enterprise is positioned to enter the burgeoning healthcare industry through its proprietary products targeting hospitals and other medical care facilities.
LuminOre CopperTouch has acquired a patented cold-metal atomization copper process from Luminore (R) Inc., the international fabrication and composite manufacturing company. Valente believes the new company will play a significant role in educating hospitals and consumers about the benefits of antimicrobial properties of copper.
“Copper is the first and only solid material to be registered by the Environmental Protection Agency as an antimicrobial surface,” Valente said. “LuminOre CopperTouch’s finish, which is virtually indistinguishable from solid forged copper, can be produced at a mere fraction of the cost of the solid material.” Production is scheduled to begin in mid-2012 in the company’s new 60,000 sq. ft. fabrication facility, immediately after LuminOre CopperTouch receives official registration from the EPA. The preregistration process is currently underway. Hospital bathroom fixtures will be the first items produced, since it has been determined that this is where the greatest potential for cross-contamination exists.
The economic impact of the problem is staggering. MRSA can cost hospitals roughly $30,000 per case, according to a study performed this year by Arrowsight Medical. In addition, all hospital-acquired infections can result in up to $33 billion in excess medical costs nationwide per year, reports the Centers for Disease Control and Prevention. “While the healthcare industry is where solutions are most urgently needed, other potential applications for the technology are unlimited,” Valente said. “Any touchable surface in any public place, like restrooms, commercial kitchens, spas and health clubs, are potential places for copper antimicrobial surfaces.”
LuminOre CopperTouch is led by Thomas Valente, CEO developer of LuminOre Composite Metals (TM), and has over thirty years of experience in the composite metals industry. He is joined by Pauline Getz, Executive Vice President, General Counsel and Secretary, who has been practicing corporate and business law for three decades.
About LuminOre CopperTouch
LuminOre CopperTouch is engaged in the strategic development of new and innovative products with copper antimicrobial surfaces. It offers education to the medical community and consumers about the beneficial properties of these surfaces. LuminOre CopperTouch surfaces are currently under preregistration with the EPA. The company is located in Carlsbad, California.
###
LuminOre CopperTouch has acquired a patented cold-metal atomization copper process from Luminore (R) Inc., the international fabrication and composite manufacturing company. Valente believes the new company will play a significant role in educating hospitals and consumers about the benefits of antimicrobial properties of copper.
“Copper is the first and only solid material to be registered by the Environmental Protection Agency as an antimicrobial surface,” Valente said. “LuminOre CopperTouch’s finish, which is virtually indistinguishable from solid forged copper, can be produced at a mere fraction of the cost of the solid material.” Production is scheduled to begin in mid-2012 in the company’s new 60,000 sq. ft. fabrication facility, immediately after LuminOre CopperTouch receives official registration from the EPA. The preregistration process is currently underway. Hospital bathroom fixtures will be the first items produced, since it has been determined that this is where the greatest potential for cross-contamination exists.
The economic impact of the problem is staggering. MRSA can cost hospitals roughly $30,000 per case, according to a study performed this year by Arrowsight Medical. In addition, all hospital-acquired infections can result in up to $33 billion in excess medical costs nationwide per year, reports the Centers for Disease Control and Prevention. “While the healthcare industry is where solutions are most urgently needed, other potential applications for the technology are unlimited,” Valente said. “Any touchable surface in any public place, like restrooms, commercial kitchens, spas and health clubs, are potential places for copper antimicrobial surfaces.”
LuminOre CopperTouch is led by Thomas Valente, CEO developer of LuminOre Composite Metals (TM), and has over thirty years of experience in the composite metals industry. He is joined by Pauline Getz, Executive Vice President, General Counsel and Secretary, who has been practicing corporate and business law for three decades.
About LuminOre CopperTouch
LuminOre CopperTouch is engaged in the strategic development of new and innovative products with copper antimicrobial surfaces. It offers education to the medical community and consumers about the beneficial properties of these surfaces. LuminOre CopperTouch surfaces are currently under preregistration with the EPA. The company is located in Carlsbad, California.
###
Contact
LuminOre CopperTouch
Pauline Getz
(760) 431-7705 ext. 100
www.luminorect.com
Pauline Getz
(760) 431-7705 ext. 100
www.luminorect.com
Contact
Categories